C57BL/6NCya-Sfrp2em1/Cya
Common Name:
Sfrp2-KO
Product ID:
S-KO-04246
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Sfrp2-KO
Strain ID
KOCMP-20319-Sfrp2-B6N-VA
Gene Name
Product ID
S-KO-04246
Gene Alias
Sdf5
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
3
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Sfrp2em1/Cya mice (Catalog S-KO-04246) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000029625
NCBI RefSeq
NM_009144
Target Region
Exon 1~3
Size of Effective Region
~6.9 kb
Detailed Document
Overview of Gene Research
Sfrp2, short for Secreted Frizzled-Related Protein 2, is a vital molecule in the Wnt signaling pathway. It can act as an antagonist of the canonical Wnt signaling pathway, and is involved in regulating multiple biological processes such as organ development and disease processes [3].
In a conditional Sfrp2 knockout in cancer-associated fibroblasts (CAFs), it was found to boost the abscopal effect of radioimmunotherapy by rewiring the vascular-immune microenvironment to promote CD8+ T cell recruitment to unirradiated tumors. This indicates that SfrP2-high CAFs serve as critical stromal regulators that can hijack the abscopal effect [1]. In the context of diabetic cardiomyopathy, overexpression of Sfrp2 in a rat model reversed apoptosis and promoted mitochondrial function, while silencing endogenous SfrP2 further promoted glucolipotoxicity-induced mitochondrial dysfunction and apoptosis in cardiomyocytes. SfrP2 exerted cardioprotective effects through the AMPK-PGC1-α-dependent pathway [2].
In conclusion, Sfrp2 plays crucial roles in multiple biological processes. Its conditional knockout in CAFs reveals its significance in regulating the abscopal effect of radioimmunotherapy. In diabetic cardiomyopathy, studies on Sfrp2, including gain-and loss-of-function experiments, show its potential as a therapeutic biomarker by modulating mitochondrial function. These findings from model-based research contribute to understanding the underlying mechanisms of related diseases and offer potential therapeutic targets.
References:
1. Zhang, Yan-Pei, Guo, Ze-Qin, Cai, Xiao-Ting, Wu, De-Hua, Dong, Zhong-Yi. 2025. PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy. In Cancer cell, , . doi:10.1016/j.ccell.2025.02.024. https://pubmed.ncbi.nlm.nih.gov/40086438/
2. Ma, Tianyi, Huang, Xiaohui, Zheng, Haoxiao, Hu, Yunzhao, Huang, Yuli. 2021. SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy. In Oxidative medicine and cellular longevity, 2021, 9265016. doi:10.1155/2021/9265016. https://pubmed.ncbi.nlm.nih.gov/34790288/
3. Wu, Yu, Liu, Xinyue, Zheng, Haoxiao, Huang, Xiaohui, Huang, Yuli. 2020. Multiple Roles of sFRP2 in Cardiac Development and Cardiovascular Disease. In International journal of biological sciences, 16, 730-738. doi:10.7150/ijbs.40923. https://pubmed.ncbi.nlm.nih.gov/32071544/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen